Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
MP2RAGE Multiple Sclerosis Magnetic Resonance Imaging at 3 T.
Pharmacological protection of CNS white matter during anoxia: actions of phenytoin, carbamazepine and diazepam.
[Optical coherence tomography in multiple sclerosis].
Physiopathology of symptoms and signs in multiple sclerosis.
Central motor conduction time may predict response to fampridine in patients with multiple sclerosis.
Complementary and alternative medicine in multiple sclerosis.
Tobacco smoking, but not Swedish snuff use, increases the risk of multiple sclerosis.
The mammalian Na+/H+ exchanger gene family--initial structure/function studies.
Imaging Microglial/Macrophage Activation in Spinal Cords of Experimental Autoimmune Encephalomyelitis Rats by Positron Emission Tomography Using the Mitochondrial 18 kDa Translocator Protein Radioligand [18F]DPA-714.
Multiple sclerosis: current and emerging disease-modifying therapies and treatment strategies.
Minocycline treatment for rheumatoid arthritis: an open dose finding study.
Vitamin A and systemic inflammation as protective factors in multiple sclerosis.
Microglia and brain macrophages in the molecular age: from origin to neuropsychiatric disease.
FDA approves Ampyra to improve walking in adults with multiple sclerosis
Natalizumab exerts direct signaling capacity and supports a pro-inflammatory phenotype in some patients with multiple sclerosis.
Neuromyelitis Optica Following Human Papillomavirus Vaccination.
Recombinant T-Cell Receptor Ligand (RTL) for Treatment of Multiple Sclerosis: A Double-Blind, Placebo-Controlled, Phase 1, Dose-Escalation Study.
Sodium accumulation is associated with disability and a progressive course in multiple sclerosis.
Tacrolimus potently inhibits human osteoclastogenesis induced by IL-17 from human monocytes alone and suppresses human Th17 differentiation.
UPDATE 2-FDA panel supports approval of Sanofi's MS drug Lemtrada
A controlled trial of natalizumab for relapsing multiple sclerosis.
Protective Associations of HDL with Blood Brain Barrier Injury in Multiple Sclerosis Patients.
MRI in multiple sclerosis: a review of the current literature.
Multiple sclerosis and oligodendroglioma: an exceptional association.
Therapeutic effect of ghrelin in experimental autoimmune encephalomyelitis by inhibiting antigen-specific Th1/Th17 responses and inducing regulatory T cells.
Pages
« first
‹ previous
…
111
112
113
114
115
116
117
118
119
…
next ›
last »